BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31471919)

  • 21. Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells.
    Tang T; Zhang G; Lau CP; Zheng LZ; Xie XH; Wang XL; Wang XH; He K; Patrick Y; Qin L; Kumta SM
    Biomed Mater; 2011 Feb; 6(1):015004. PubMed ID: 21205994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
    He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
    Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of bone.
    Kimura A; Toda Y; Matsumoto Y; Yamamoto H; Yahiro K; Shimada E; Kanahori M; Oyama R; Fukushima S; Nakagawa M; Setsu N; Endo M; Fujiwara T; Matsunobu T; Oda Y; Nakashima Y
    Sci Rep; 2022 Aug; 12(1):13438. PubMed ID: 35927428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
    Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
    Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
    Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
    Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological characteristics of a novel giant cell tumor cell line derived from spine.
    Zhou Z; Li Y; Xu L; Wang X; Chen S; Yang C; Xiao J
    Tumour Biol; 2016 Jul; 37(7):9681-9. PubMed ID: 26801673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p62 overexpression promotes neoplastic stromal cell proliferation and is associated with the recurrence of giant cell tumor of bone.
    Liu S; Ye F; Li D; He C; He H; Zhang J
    Oncol Lett; 2020 Oct; 20(4):86. PubMed ID: 32863919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stro-1(+) stromal cells have stem-like features in giant cell tumor of bone.
    Lan J; Liu X; Rong W; Wei F; Jiang L; Yu H; Dang G; Liu Z
    J Surg Oncol; 2012 Dec; 106(7):826-36. PubMed ID: 22605660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro?
    Zhou YS; Liu YS; Tan JG
    Chin Med J (Engl); 2006 Aug; 119(15):1278-86. PubMed ID: 16919187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
    Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
    Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Titanium Surface Microtopography and Simvastatin on Growth and Osteogenic Differentiation of Human Mesenchymal Stem Cells in Estrogen-Deprived Cell Culture.
    Arpornmaeklong P; Pripatnanont P; Chookiatsiri C; Tangtrakulwanich B
    Int J Oral Maxillofac Implants; 2017; 32(1):e35-e46. PubMed ID: 28095523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
    Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
    Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.
    Mukaihara K; Suehara Y; Kohsaka S; Akaike K; Tanabe Y; Kubota D; Ishii M; Fujimura T; Kazuno S; Okubo T; Takagi T; Yao T; Kaneko K; Saito T
    PLoS One; 2016; 11(2):e0148401. PubMed ID: 26863138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
    Knowles HJ; Athanasou NA
    J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2020 Oct; 33(4):1321-1328. PubMed ID: 32815117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone.
    Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Fukushima S; Toda Y; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
    Hum Cell; 2022 Sep; 35(5):1621-1629. PubMed ID: 35653034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells.
    Song C; Guo Z; Ma Q; Chen Z; Liu Z; Jia H; Dang G
    Biochem Biophys Res Commun; 2003 Aug; 308(3):458-62. PubMed ID: 12914771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could MTA be a novel medicine on the recurrence therapy for GCTB?
    Qin H; Cai J; Fang J; Xu H; Gong Y
    Med Hypotheses; 2010 Feb; 74(2):368-9. PubMed ID: 19656634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.